Top Companies
Form Screener
Cluster Buys
Sectors
Feedback
FAQ
Blog
Newsletter
Xenon Pharmaceuticals Inc. (XENE)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Billed Annually
SAVE 20%/mo!
Billed Monthly
Director
$50/mo
* Billed monthly
All Insider Trades
Monthly Newsletter
Unlimited Company Graphs
Download Data
Sector Insights
Custom Watchlists
Notifications
Real Time Emails
Direct Access to Team
Feature Requests
C-Suite
$75/mo
* Billed monthly
All Insider Trades
Monthly Newsletter
Unlimited Company Graphs
Download Data
Sector Insights
Custom Watchlists
Notifications
Real Time Emails
Direct Access to Team
Feature Requests
Checkout
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
24 Aug 2023
Svoronos Dawn
Director
Xenon Pharmaceuticals Inc.
(XENE)
25,000
-50%
25,000
$38.70
$967,500.00
SELL
30 May 2023
PIMSTONE SIMON N.
Director
Xenon Pharmaceuticals Inc.
(XENE)
6,000
-95%
131,245
$38.90
$5,104,970.00
SELL
24 May 2023
MORTIMER IAN
PRESIDENT & CEO, Director, Officer
Xenon Pharmaceuticals Inc.
(XENE)
24,213
-56%
31,655
$41.41
$1,310,930.90
SELL
24 Mar 2023
KENNEY CHRISTOPHER JOHN
Chief Medical Officer, Officer
Xenon Pharmaceuticals Inc.
(XENE)
0
-100%
700
$35.01
$24,507.00
SELL
12 Aug 2022
EMPFIELD JAMES R.
EVP, Drug Discovery, Officer
Xenon Pharmaceuticals Inc.
(XENE)
31,875
-64%
57,743
$38.31
$2,211,978.50
SELL
12 Aug 2022
PIMSTONE SIMON N.
Director
Xenon Pharmaceuticals Inc.
(XENE)
26,000
-87%
177,135
$38.25
$6,775,148.50
SELL
4 Mar 2022
ROBIN SHERRINGTON
EVP, Strategy & Innovation, Officer
Xenon Pharmaceuticals Inc.
(XENE)
32,232
-40%
21,710
$30.50
$662,207.60
SELL
4 Mar 2022
PIMSTONE SIMON N.
Director
Xenon Pharmaceuticals Inc.
(XENE)
195,635
-21%
54,962
$29.28
$1,609,320.60
SELL
4 Mar 2022
EMPFIELD JAMES R.
EVP, Drug Discovery, Officer
Xenon Pharmaceuticals Inc.
(XENE)
41,048
-55%
51,168
$30.63
$1,567,394.00
BUY
21 Jan 2022
KENNEY CHRISTOPHER JOHN
Chief Medical Officer, Officer
Xenon Pharmaceuticals Inc.
(XENE)
700
+100%
700
$28.81
$20,167.00
BUY
6 Dec 2021
Von Seggern Christopher
Chief Commercial Officer, Officer
Xenon Pharmaceuticals Inc.
(XENE)
4,000
+100%
4,000
$24.40
$97,600.00
SELL
15 Nov 2021
PIMSTONE SIMON N.
Director
Xenon Pharmaceuticals Inc.
(XENE)
210,186
-7%
17,557
$31.33
$550,060.80
SELL
28 May 2021
ROBIN SHERRINGTON
EVP, Strategy & Innovation, Officer
Xenon Pharmaceuticals Inc.
(XENE)
35,144
-14%
6,067
$18.81
$114,120.27
SELL
27 May 2021
HOLLER FRANK A
Director
Xenon Pharmaceuticals Inc.
(XENE)
152,138
-6%
11,064
$18.68
$206,701.31
SELL
29 May 2020
PIMSTONE SIMON N.
CEO, Director, Officer
Xenon Pharmaceuticals Inc.
(XENE)
255,186
-3%
8,000
$14.16
$113,240.00
SELL
20 Sep 2019
PIMSTONE SIMON N.
CEO, Director, Officer
Xenon Pharmaceuticals Inc.
(XENE)
258,122
-3%
10,395
$9.51
$98,856.45
SELL
19 Sep 2019
HOLLER FRANK A
Director
Xenon Pharmaceuticals Inc.
(XENE)
118,955
-9%
12,806
$9.32
$119,336.34
SELL
16 Sep 2019
HOLLER FRANK A
Director
Xenon Pharmaceuticals Inc.
(XENE)
131,761
-6%
9,437
$9.30
$87,778.12
SELL
13 Sep 2019
AZAB MOHAMMAD
Director
Xenon Pharmaceuticals Inc.
(XENE)
57,561
-0%
23
$9.31
$214.18
BUY
15 Nov 2017
AZAB MOHAMMAD
Director
Xenon Pharmaceuticals Inc.
(XENE)
44,210
+51%
15,000
$2.22
$33,280.50
BUY
21 Sep 2017
AZAB MOHAMMAD
Director
Xenon Pharmaceuticals Inc.
(XENE)
29,210
+52%
10,000
$2.95
$29,500.00
BUY
18 Aug 2017
WINQUIST RAYMOND
Head, Translational Research, Officer
Xenon Pharmaceuticals Inc.
(XENE)
1,000
+100%
1,000
$3.00
$2,995.00
BUY
17 Aug 2017
AZAB MOHAMMAD
Director
Xenon Pharmaceuticals Inc.
(XENE)
19,210
+49%
6,335
$2.90
$18,362.59
BUY
15 Aug 2017
EMPFIELD JAMES R.
SVP, Drug Discovery, Officer
Xenon Pharmaceuticals Inc.
(XENE)
10,000
+100%
10,000
$2.48
$24,824.00
BUY
14 Aug 2017
BVF PARTNERS L P/IL
10% Owner
Xenon Pharmaceuticals Inc.
(XENE)
1,674,468
+3%
60,202
$2.61
$157,266.90
BUY
14 Aug 2017
Svoronos Dawn
Director
Xenon Pharmaceuticals Inc.
(XENE)
50,000
+100%
50,000
$2.82
$140,770.00
BUY
14 Aug 2017
Hayden Michael R
Director
Xenon Pharmaceuticals Inc.
(XENE)
161,187
+10%
15,000
$2.75
$41,247.00
BUY
11 Aug 2017
GANNON STEVEN
Director
Xenon Pharmaceuticals Inc.
(XENE)
15,000
+100%
15,000
$2.82
$42,267.00
BUY
10 Aug 2017
PATOU GARY
Director
Xenon Pharmaceuticals Inc.
(XENE)
12,500
+150%
7,500
$2.78
$20,835.75
BUY
10 Aug 2017
SCHELLER RICHARD H
Director
Xenon Pharmaceuticals Inc.
(XENE)
7,000
+100%
7,000
$2.85
$19,950.00
BUY
10 Aug 2017
MORTIMER IAN
CFO & COO, Officer
Xenon Pharmaceuticals Inc.
(XENE)
6,000
+166%
15,000
$2.88
$43,225.00
BUY
10 Aug 2017
PIMSTONE SIMON N.
President & CEO, Director, Officer
Xenon Pharmaceuticals Inc.
(XENE)
217,847
+2%
6,000
$2.90
$17,400.00
BUY
8 Aug 2017
PATOU GARY
Director
Xenon Pharmaceuticals Inc.
(XENE)
5,000
+100%
5,000
$3.00
$15,002.50
BUY
27 Jun 2017
BVF PARTNERS L P/IL
10% Owner
Xenon Pharmaceuticals Inc.
(XENE)
1,635,032
+5%
85,461
$4.00
$341,844.00
BUY
21 Jun 2017
BVF PARTNERS L P/IL
10% Owner
Xenon Pharmaceuticals Inc.
(XENE)
1,588,237
+1%
20,411
$4.00
$81,644.00
BUY
15 Jun 2017
BVF PARTNERS L P/IL
10% Owner
Xenon Pharmaceuticals Inc.
(XENE)
1,577,332
+1%
26,408
$3.84
$101,517.67
BUY
6 Jun 2017
BVF PARTNERS L P/IL
10% Owner
Xenon Pharmaceuticals Inc.
(XENE)
1,562,494
+29%
358,698
$3.81
$1,366,145.80
SELL
15 Dec 2016
HOLLER FRANK A
Director
Xenon Pharmaceuticals Inc.
(XENE)
115,869
-20%
30,000
$7.85
$235,500.00
SELL
19 Aug 2016
HOLLER FRANK A
Director
Xenon Pharmaceuticals Inc.
(XENE)
145,869
-7%
11,938
$7.65
$91,337.64
SELL
16 Aug 2016
HOLLER FRANK A
Director
Xenon Pharmaceuticals Inc.
(XENE)
157,807
-10%
18,062
$7.93
$143,156.05
BUY
24 Jun 2016
MORTIMER IAN
CFO & COO, Officer
Xenon Pharmaceuticals Inc.
(XENE)
1,000
+123%
5,300
$6.22
$32,940.00
Home